Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?

被引：4
作者：
Knobel, H [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Mar, Dept Internal Med Infect Dis, Barcelona 08003, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1086/426596
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：164 / 166
页数：3
相关论文
共 12 条
[1]   Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates [J].
Bangsberg, DR ;
Porco, TC ;
Kagay, C ;
Charlebois, ED ;
Deeks, SG ;
Guzman, D ;
Clark, R ;
Moss, A .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :162-165
[2]   Paradoxes of adherence and drug resistance to HIV antiretroviral therapy [J].
Bangsberg, DR ;
Moss, AR ;
Deeks, SG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :696-699
[3]   Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine [J].
Cahn, P ;
Vibhagool, A ;
Schechter, M ;
Soto-Ramirez, L ;
Carosi, G ;
Smaill, F ;
Jordan, JC ;
Pharo, CE ;
Thomas, NE ;
Steele, HM .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) :1115-1123
[4]   Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine [J].
Kempf, DJ ;
King, MS ;
Bernstein, B ;
Cernohous, P ;
Bauer, E ;
Moseley, J ;
Gu, K ;
Hsu, A ;
Brun, S ;
Sun, E .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (01) :51-60
[5]   Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients:: the GEEMA Study [J].
Knobel, H ;
Alonso, J ;
Casado, JL ;
Collazos, J ;
González, J ;
Ruiz, I ;
Kindelan, JM ;
Carmona, A ;
Juega, J ;
Ocampo, A .
AIDS, 2002, 16 (04) :605-613
[6]   Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors [J].
Maggiolo, F ;
Ravasio, L ;
Ripamonti, D ;
Gregis, G ;
Quinzan, G ;
Arici, C ;
Airoldi, M ;
Suter, F .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) :158-163
[7]   Predictors of virologic failure and resistance in HIV-Infected patients treated with nevirapineor efavirenz-based antiretroviral therapy [J].
Parienti, JJ ;
Massari, V ;
Descamps, D ;
Vabret, A ;
Bouvet, E ;
Larouzé, B ;
Verdon, R .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1311-1316
[8]   Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence [J].
Press, N ;
Tyndall, MW ;
Wood, E ;
Hogg, RS ;
Montaner, JSG .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S112-S117
[9]   Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance [J].
Sethi, AK ;
Celentano, DD ;
Gange, SJ ;
Moore, RD ;
Gallant, JE .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) :1112-1118
[10]   Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens [J].
Trotta, MP ;
Ammassari, A ;
Cozzi-Lepri, A ;
Zaccarelli, M ;
Castelli, F ;
Narciso, P ;
Melzi, S ;
De Luca, A ;
Monforte, AD ;
Antinori, A .
AIDS, 2003, 17 (07) :1099-1102
12